Guidelines for the use of androgens in men.
Material type:
TextPublication details: Geneva : World Health Organization, 1992.Description: 69 pSubject(s): NLM classification: - WJ 875
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
DOCUMENT
|
WHO HQ READING-RM | WJ 875 92GU (Browse shelf(Opens below)) | 1 | Available | 00035539 | ||
Books
|
WHO HQ BORROWABLE-COLL-STACKS | WJ 875 92GU (Browse shelf(Opens below)) | 2 | Withdrawn | 00035540 |
Browsing WHO HQ shelves, Shelving location: BORROWABLE-COLL-STACKS Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| WJ 834 90CE Cellular and molecular events in spermiogenesis : | WJ 858 83IN An International survey of distributions of histologic types of tumours of the testis and ovary / | WJ 858 86GE Germ cell tumours, II : | WJ 875 92GU Guidelines for the use of androgens in men. | WJ 875 94IN Inhibin and inhibin-related proteins / | WK 100 2009TH Therapeutic guidelines:Endocrinology | WK 100 75VI Human endocrinology : |
Appendix: Consensus report / Workshop Conference on Androgen Therapy : Biologic and Clinical Consequences, 17 - 20 January 1990, Marco Island, Florida, U.S.A.
eng.
WHODOC
WHO document
WHO/HRP/MALE/92. Unpublished
This guideline is out of date and a revision is pending.
4
There are no comments on this title.